Alkermes (ALKS) Research & Development (2010 - 2026)

Alkermes (ALKS) has 17 years of Research & Development data on file, last reported at $103.3 million in Q1 2026.

• On a quarterly basis, Research & Development rose 43.9% year-over-year to $103.3 million in Q1 2026; TTM through Mar 2026 was $511.5 million, a 53.89% increase from a year earlier, with the FY2025 full-year figure at $480.0 million, up 7.57% from the prior year.
• Research & Development for Q1 2026 stood at $103.3 million, down from $249.1 million in the prior quarter.
• Over the last five years, Research & Development for ALKS reached as high as $249.1 million in Q4 2025 and fell as low as $59.6 million in Q2 2024.
• Historically, Research & Development has averaged $92.6 million across 5 years, with a median of $81.7 million in 2025.
• Across the five-year window, Research & Development jumped 697.6% in 2022 and slumped 35.4% in 2023, its largest moves.
• Year by year, Research & Development stood at $103.0 million in 2022, then dropped by 28.19% to $73.9 million in 2023, then jumped by 33.75% to $98.9 million in 2024, then jumped by 151.89% to $249.1 million in 2025, then plunged by 58.51% to $103.3 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $103.3 million in Q1 2026, $249.1 million in Q4 2025, and $81.7 million in Q3 2025.